# US 2015/0104809 A1 · Detection and treatment of cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104809 A1
- Document ID: US20150104809A1
- Status: Published application
- Kind: A1
- Application number: 14/055,396
- Filed: 2013-10-16
- Published: 2015-04-16
- Earliest claimed: 2013-10-16
- Assignees: University of Essex Enterprises Limited
- Applicants: University of Essex Enterprises Ltd.
- Inventors: Metodi Vladimirov Metodiev
- Web page: https://patentgrep.com/patent/US20150104809A1

## CPC

- G01N 33/5759: {involving compounds localised on the membrane of tumour or cancer cells}
- G01N 33/5758: {involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites}
- G01N 2333/70539: MHC-molecules, e.g. HLA-molecules
- G01N 2440/14: phosphorylation
- G01N 2800/56: Staging of a disease; Further complications associated with the disease
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to a method for diagnosing, evaluating the prognosis of a cancer patient and evaluating the aggressiveness of a cancer. The methods comprise detecting the phosphorylation status of a Scribble protein, a fragment or variant thereof, wherein the phosphorylation status is indicative of cancer, prognosis and the aggressiveness of a cancer. In one embodiment the cancer is breast cancer.

## Claims

### Claim 1

A method of diagnosing cancer in a patient, the method comprising detecting the phosphorylation status of a Scribble protein, a fragment or variant thereof, wherein said phosphorylation status is indicative of cancer.

### Claim 2 (depends on 1)

A method of claim 1, comprising detecting the phosphorylation status of one or more residues of a Scribble protein or fragment or variant thereof.

### Claim 3 (depends on 1)

The method of claim 1, comprising detecting the phosphorylation status of at least one of the following residues S1306, S1309, S1348 and S1448 or a combination thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the patient is a cancer patient or is at risk of developing cancer.

### Claim 5 (depends on 4)

The method of claim 4, wherein the patient's cancer is an epithelial cancer.

### Claim 6 (depends on 5)

The method of claim 5, wherein the patient's cancer is breast, pancreas, bone, liver, stomach, lung, colorectal, bladder, prostate or ovarian cancer.

### Claim 7 (depends on 6)

The method of claim 6, wherein the cancer is breast cancer and wherein the breast cancer tumour does not express at least one marker selected from the group consisting of oestrogen receptor (ER), progesterone receptor (PgR) and the ErbB2 receptor.

### Claim 8 (depends on 1)

The method of claim 1, wherein detecting the phosphorylation status comprises obtaining a sample from said patient and contacting the sample with at least one antibody that is capable of specifically binding phosphorylated or unphosphorylated residues of a Scribble protein, fragment or variant thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein detecting the phosphorylation status comprises obtaining a sample from said patient and detecting the phosphorylation status by mass spectrometry.

### Claim 10 (depends on 1)

The method of claim 1, further comprising detecting the expression of one or more other biomarkers.

### Claim 11

A method for evaluating the prognosis of cancer, the method comprising detecting the phosphorylation status of a Scribble protein, a fragment or variant thereof, wherein the phosphorylation status is indicative of prognosis.

### Claim 12

A method for detecting the phosphorylation status of a Scribble protein with SEQ ID NO: 1, a fragment or variant thereof, the method comprising:
obtaining a sample from a patient and contacting the sample with at least one antibody that is capable of specifically binding phosphorylated or unphosphorylated residues S1306, S1309, S1348 and S1448 or a combination thereof in the Scribble protein, fragment or variant thereof.

### Claim 13 (depends on 12)

The method of claim 12, wherein the method is performed in conjunction with at least one of the following: evaluating cancer prognosis, developing a cancer treatment plan, assessing the efficiency of cancer treatment and the likelihood of metastases.

### Claim 14

An antibody capable of selectively binding to at least one phosphorylated or unphosphorylated residue in a Scribble protein with SEQ ID NO: 1, or fragment or variant thereof, selected from residues S1306, S1309, S1348 and S1448 or a combination thereof.

### Claim 15 (depends on 1)

A kit for use in the method of claim 1 comprising at least one antibody capable of selectively binding to at least one phosphorylated or unphosphorylated residue in a Scribble protein with SEQ ID NO: 1, or fragment or variant thereof, selected from residues S1306, S1309, S1348 and S1448 or a combination thereof, wherein said kit further comprises agents for the detection of the at least one antibody binding to said phosphorylated residues in Scribble.

### Claim 16 (depends on 15)

The kit of claim 15, wherein said kit further comprises instructions for use.

### Claim 17 (depends on 11)

A kit for use in the method of claim 11 comprising at least one antibody capable of selectively binding to at least one phosphorylated or unphosphorylated residue in a Scribble protein with SEQ ID NO: 1, or fragment or variant thereof, selected from residues S1306, S1309, S1348 and S1448 or a combination thereof, wherein said kit further comprises agents for the detection of the at least one antibody binding to said phosphorylated residues in Scribble.

### Claim 18 (depends on 17)

The kit of claim 17, wherein said kit further comprises instructions for use.

### Claim 19 (depends on 12)

A kit for use in the method of claim 12 comprising at least one antibody capable of selectively binding to at least one phosphorylated or unphosphorylated residue in a Scribble protein with SEQ ID NO: 1, or fragment or variant thereof, selected from residues S1306, S1309, S1348 and S1448 or a combination thereof, wherein said kit further comprises agents for the detection of the at least one antibody binding to said phosphorylated residues in Scribble.

### Claim 20 (depends on 19)

The kit of claim 19, wherein said kit further comprises instructions for use.
